Seeing Is Believing
Currently out of the existing stock ratings of Yun Zhong, 48 are a BUY (82.76%), 10 are a HOLD (17.24%).
Analyst Yun Zhong, currently employed carries an average stock price target met ratio of 18.69% that have a potential upside of 25.7% achieved within 89 days. Previously, Yun Zhong worked at BTIG.
Yun Zhong’s has documented 101 price targets and ratings displayed on 17 stocks. The coverage was on Healthcare, Financial Services sectors.
Most recent stock forecast was given on SRPT, Sarepta Therapeutics at 21-Oct-2024.
Analyst best performing recommendations are on GRPH (GRAPHITE BIO).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 11/11/2020. The price target of $140 was fulfilled within 2 days with a profit of $5.27 (3.91%) receiving and performance score of 19.56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$0.4
$0.01 (2.56%)
2 years 29 days ago
(25-Oct-2022)
1/1 (100%)
$0.01 (2.56%)
2
Buy
2 years 30 days ago
(24-Oct-2022)
1/10 (10%)
$13.99 (348.88%)
848
Hold
$12
2 years 30 days ago
(24-Oct-2022)
0/2 (0%)
$2.73 (29.45%)
Hold
2 years 30 days ago
(24-Oct-2022)
0/1 (0%)
$7.55 (308.16%)
Hold
$11
2 years 1 months 25 days ago
(29-Sep-2022)
0/2 (0%)
$6.72 (157.01%)
Which stock is Yun Zhong is most bullish on?
Which stock is Yun Zhong is most reserved on?
What Year was the first public recommendation made by Yun Zhong?